Previously we reported that IL4Rα and IL13Rα1 (Type II receptor) is a prognostic marker and involved in the development of clear cell renal cell carcinoma (ccRCC) through JAK2/FOXO3 pathway [19]. This evidence concerns the gene JAK2 and nonpapillary renal cell carcinoma.